The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
True
Open accessAbstract
The family history of cancer in children treated for a solid malignant tumour in the Paediatric Oncology Department at Institute Gustave-Roussy, has been investigated. In order to determine the role of germline p53 mutations in genetic predisposition to childhood cancer, germline p53 mutations were sought in individuals with at least one relative (first- or second-degree relative or first cousin) affected by any cancer before 46 years of age, or affected by multiple cancers. Screening for germline p53 mutation was possible in 268 index cases among individuals fulfilling selection criteria. Seventeen (6.3%) mutations were identified, of which 13 were inherited and four were de novo. Using maximum likelihood methods that incorporate retrospective family data and correct for ascertainment bias, the lifetime risk of cancer for mutation carriers was estimated to be 73% for males and nearly 100% for females with a high risk of breast cancer accounting for the difference. The risk of cancer associated with such mutations is very high and no evidence of low penetrance mutation was found. These mutations are frequently inherited but de novo mutations are not rare.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families
Birch, Hartley, Tricker, Prosser, P., Condie, Kelsey, Harris, Jones, Binchy, Crowther, et al. (1994) · Cancer Research · Cited by 475
A simple p53 functional assay for screening cell lines, blood, and tumors.
Flaman, J. M., Frebourg, T., Moreau, V, Charbonnier, F., Martin, C., Chappuis, P., Sappino, A. P., Limacher, I. M., Bron, L., & Benhattar, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3963 · Cited by 454
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
Birch, J. M., Hartley, A. L., Tricker, K. J., Prosser, J., Condie, A., Kelsey, A. M., Harris, M., Jones, P. H. M., Binchy, A., & Crowther, D. (1994) · PubMed · Cited by 421
Malkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., Andersen, T. I., Børresen, A.-L., Li, F. P., Garber, J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262002 · Cited by 379
Li-Fraumeni syndrome – a molecular and clinical review
Varley, J., Evans, D., & Birch, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.328 · Cited by 358
Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma
Toguchida, J., Yamaguchi, T., Dayton, S. H., Beaughamp, R. L., Herrera, G. E., Ishizaki, K., Yamamuro, T., Meyers, P. A., Little, J. B., Sasaki, M. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262001 · Cited by 307
Follow-up study of twenty-four families with Li-Fraumeni syndrome.
Garber, J. E., Goldstein, A. M., Kantor, A. F., Dreyfus, M., Fraumeni, J. F., & Li, F. P. (1991) · PubMed · Cited by 275
Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors
Varley, J. M., McGown, G., Thorncroft, M., James, L. A., Margison, G. P., Forster, G., Evans, D. G. R., Harris, M., Kelsey, A. M., & Birch, J. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302575 · Cited by 266
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Varley, J. M., McGown, G., Thorncroft, M. R., Santibanez‐Koref, M., Kelsey, A. M., Tricker, K. J., Evans, D. G., & Birch, J. M. (1997) · PubMed · Cited by 263
Screening patients for heterozygous p53 mutations using a functional assay in yeast
Ishioka, C., Frebourg, T., Yan, Y.-X., Vidal, M., Friend, S. H., Schmidt, S., & Iggo, R. (1993) · Nature Genetics · doi:10.1038/ng1093-124 · Cited by 243
Germline mutations in the TP53 gene.
Eeles, R. A. (1995) · PubMed · Cited by 211
Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
Frébourg, T., Barbier, N., Yan, Y.-X., Garber, J. E., Dreyfus, M., Fraumeni, J. F., Li, F. P., & Friend, S. H. (1995) · Europe PMC (PubMed Central) · Cited by 202
Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
McIntyre, J. F., Smith-Sorensen, B., Friend, S. H., Kassell, J., Borresen, A. L., Yan, Y. X., Russo, C., Sato, J., Barbier, N., & Miser, J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.925 · Cited by 200
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
Lustbader, E. D., Williams, W. R., Bondy, M. L., Strom, S. S., & Strong, L. C. (1992) · PubMed · Cited by 148
Kony, S., de Vathaire, F., Chompret, A., Shamsaldim, A., Grimaud, E., Raquin, M., Oberlin, O., Brugières, L., Feunteun, J., Eschwège, F., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01116-1 · Cited by 143
p53 and the Li-Fraumeni syndrome
Malkin, D. M. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90014-0 · Cited by 116
The Li–Fraumeni Syndrome: From Clinical Epidemiology to Molecular Genetics
Strong, L. C., Williams, W. R., & Tainsky, M. A. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116271 · Cited by 91
Brugières, L., Gardes, M., Moutou, C., Chompret, A., Méresse, V., Martin, A., Poisson, N., Flamant, F., Bonaïti‐Pellié, C., & Lemerle, J. (1993) · PubMed · Cited by 71
Lomax, M. E., Barnes, D. M., Gilchrist, R., Picksley, S. M., Varley, J. M., & Camplejohn, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201133 · Cited by 65
Bihan-Benjamin, C. L., Moutou, C., Brugières, L., Feunteun, J., & Bonaïti‐Pellié, C. (1995) · Genetic Epidemiology · doi:10.1002/gepi.1370120103 · Cited by 61
Varley, J. M., McGown, G., Thorncroft, M. R., Cochrane, S. M., Morrison, P., Woll, P. J., Kelsey, A. M., Mitchell, E. L. D., Boyle, J. M., Birch, J. M., et al. (1996) · PubMed · Cited by 40
A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.
Felix, C. A., Strauss, E. A., D'Amico, D., Tsokos, M., Winter, S. C., Mitsudomi, T., Nau, M. M., Brown, D., Leahey, A., & Horowitz, M. (1993) · PubMed · Cited by 31
A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors
Gutiérrez, M. I., Bhatla, K. G., Berreiro, C., Spangler, G., Schvartzman, E., Muriel, F. S., & Magrath, L. T. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2247 · Cited by 23
Speiser, P., Gharehbaghi-Schnell, E., Eder, S., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.350 · Cited by 17
A method for estimating cancer risk in p53 mutation carriers.
Le Bihan, C., & Bonaïti‐Pellié, C. (1994) · PubMed · Cited by 11
Cited by
Realizing the promise of cancer predisposition genes
Rahman, N. (2014) · Nature · doi:10.1038/nature12981 · Cited by 624
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Gonzalez, K. D., Noltner, K. A., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Nguyen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6959 · Cited by 609
Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0408 · Cited by 534
Malkin, D. (2011) · Genes & Cancer · doi:10.1177/1947601911413466 · Cited by 508
Metadata
- Venue
- British Journal of Cancer
- Published
- 2000
- Volume
- 82
- Issue
- 12
- Pages
- 1932-1937
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1514348119
- Cited by
- 372
- References
- 27
- FWCI
- 1.89
- Type
- journal article
- Language
- fr
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.